OSI-930 is a potent and selective inhibitor of c-Kit, a receptor tyrosine kinase that is overexpressed in a variety of cancers, including gastrointestinal stromal tumors (GISTs) and acute myeloid leukemia (AML). This evidence concerns the gene NTRK1 and cancer.